Laura Gálvez-Carvajal

5PUBLICATIONS
43CO-AUTHORS
Haematological tumoursPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 13, 2025
Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial.

Sara Fernández-Castillejo, Joan Badia, Luís de la Cruz-Merino

|Oct 21, 2022
Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study.

Ismael Fernández-Miranda, Lucía Pedrosa, Marta Llanos

|Aug 26, 2022
High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade.

Juan Luis Onieva, Qingyang Xiao, Miguel-Ángel Berciano-Guerrero

|Jun 21, 2022
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis.

Natalia Palazón-Carrión, Alejandro Martín García-Sancho, Esteban Nogales-Fernández

|Mar 22, 2021
Neoadjuvant immunotherapy in resectable head and neck cancer: oral cavity carcinoma as a potential research model.

Vanesa Gutiérrez Calderón, Alexandra Cantero González, Laura Gálvez Carvajal

Pageof 1

Frequent Collaborators

3 joint publications

Mariano Provencio-Pulla

3 joint publications

Margarita Sánchez-Beato

3 joint publications

Antonio Rueda-Domínguez

3 joint publications

Natividad Martínez-Banaclocha